Key Takeaways & Executive Findings
- •• Non-vascularized bone grafts remain the mainstream treatment for scaphoid nonunion, with cancellous bone achieving healing rates of 85%-100% for non-deformed cases and corticocancellous bone providing superior structural support (88%-93%). • Vascularized bone grafts significantly improve outcomes in complex cases, with free medial femoral condyle flaps showing a 95% healing rate and free iliac bone flaps achieving 91.7%-100% success, albeit with high technical demands. • Distal radius donor sites have fewer complications (5%) compared to iliac crest (18%), with no significant difference in healing rates between the two. • Individualized treatment is crucial: non-vascularized grafts suit simple fractures with good blood supply, while vascularized grafts are reserved for ischemic necrosis or complex deformities. • Future directions include standardized MRI grading, biological enhancements (BMP-2, 3D-printed scaffolds), and wider adoption of microsurgical techniques to optimize outcomes.
Abstract
BACKGROUND: Due to the relatively special symptoms and anatomical structure of scaphoid fractures, untreated fractures or those with delayed treatment often lead to non-union of the fracture, carpal joint collapse, or loss of function, subsequently resulting in persistent or intermittent pain, swelling, and limited mobility in the carpal joint. Currently, although there are a wide variety of bone grafting techniques and the choice of treatment methods is complex, there is still no consensus on which bone grafting surgical method is superior. OBJECTIVE: To review the research status of scaphoid nonunion, summarize different bone grafting surgeries for the treatment of nonunion of fractures at home and abroad in recent years, explore the clinical efficacy, advantages and disadvantages of various bone grafting techniques, and provide guidance for clinical diagnosis and treatment. METHODS: A computer was used to search for relevant articles published in the PubMed, MEDLINE, EMBASE, CNKI, China Medical Library, VIP, and WanFang databases from 1980 to 2024. The Chinese and English search terms were “scaphoid nonunion, surgery, bone graft, bone flap, scaphoid proximal pole.” A total of 687 articles were retrieved, and 54 articles were selected for review through inclusion and exclusion criteria. RESULTS AND CONCLUSION: (1) Non-vascularized graft is still the mainstream treatment for scaphoid nonunion. Among them, simple cancellous bone transplantation has fast bone formation (healing rate 85%-100%) and is suitable for cases without deformity; cortical cancellous bone has strong support (healing rate 88%-93%), which is more conducive to restoring the morphology of the scaphoid. (2) There is no significant difference in the healing rate between iliac bone and distal radial donors, but the distal radial donor site has fewer complications (5% vs. 18%). (3) Vascularized grafts can significantly improve the efficacy of complex cases: radial styloid bone flap healing rate 81%-92%, pronator quadratus pedicled flap healing rate 93.3%, free medial femoral condyle flap has outstanding effect on joint surface reconstruction (healing rate 95%), free iliac bone flap success rate 91.7%-100%, but high technical requirements. (4) The treatment of scaphoid nonunion needs to follow the principle of individualization: non-vascularized grafts are suitable for simple, well-vascularized fractures, while vascularized grafts are aimed at ischemic necrosis or complex deformities. (5) In the future, standardized imaging evaluation (such as MRI grading), biological enhancement techniques (bone morphogenetic protein 2, 3D printed scaffolds), and the popularization of microsurgery are needed to improve efficacy, while combining patient age and occupational needs to formulate the optimal plan, balancing functional recovery and complication prevention.
1. Introduction
Currently, the clinical treatment of scaphoid nonunion remains a major challenge, especially in cases accompanied by avascular necrosis. Nonunion often leads to persistent or intermittent wrist pain, swelling, and further progression to limited wrist motion. Statistics indicate that scaphoid fractures account for 2%-3% of all fractures, 10% of all hand fractures, and 60%-80% of carpal bone fractures. Fractures typically occur after a fall or during sports when the wrist is in a radially deviated and dorsiflexed position; women are more prone to low-energy injuries, while men often sustain high-energy injuries. The annual incidence ranges from 1.5 to 29 per 100,000 people. Kakar et al. consider intraoperative assessment of bleeding from the proximal fragment as the gold standard for diagnosing scaphoid fractures. Due to the relatively unique symptoms and anatomical structure of the scaphoid, untreated or delayed fractures frequently result in nonunion.
The diagnostic criteria for scaphoid nonunion are inconsistent, leading to varying reported incidence rates. According to the literature, 5%-15% of scaphoid fractures progress to nonunion, with much lower rates for non-displaced fractures when adequately treated and protected (approaching zero). However, when proximal pole fractures are displaced, the nonunion rate can reach nearly 55%. High-risk factors for nonunion include delayed diagnosis, inadequate immobilization, fracture displacement, and proximal location. The primary anatomical factor is the blood supply: the dorsal carpal branch of the radial artery enters the scaphoid at the waist and tubercle, supplying 70%-80% of the blood flow to the distal pole, while the proximal pole, covered almost entirely by articular cartilage, has no vascular entry, receiving only about 30% of the blood supply. This unique vascularity predisposes the proximal pole to avascular necrosis and nonunion.
Loading authentic research manuscript (Pages 1–5)...
Guo Wen, Gao Binli, Wang Yang, Lin Sen (2026). Bone grafting for repairing scaphoid nonunion. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21427
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the main types of bone grafts used for scaphoid nonunion?
The main types are non-vascularized bone grafts (cancellous, corticocancellous) and vascularized bone grafts (e.g., radial styloid, pronator quadratus pedicled, free medial femoral condyle, free iliac). Non-vascularized grafts are simpler and suitable for well-vascularized nonunions without deformity, while vascularized grafts are preferred for avascular necrosis or complex cases.
Which bone graft has the highest healing rate for scaphoid nonunion?
Among vascularized grafts, free medial femoral condyle flaps have shown a healing rate of 95%, and free iliac bone flaps achieve 91.7%-100%. Among non-vascularized grafts, cancellous bone grafts have healing rates of 85%-100%, but they are less suitable for deformed or unstable fractures.
What are the advantages of using distal radius as a donor site over iliac crest?
Distal radius donor sites have fewer complications (5%) compared to iliac crest (18%), and there is no significant difference in healing rates between the two. This makes distal radius a favorable option when a corticocancellous graft is needed.
How does avascular necrosis affect the choice of bone grafting technique?
Avascular necrosis of the proximal pole significantly compromises healing. In such cases, vascularized bone grafts are recommended because they bring their own blood supply, improving the chance of union. Non-vascularized grafts are less effective in this scenario.
What future developments are expected in the treatment of scaphoid nonunion?
Future directions include standardized imaging evaluation (e.g., MRI grading), biological enhancements such as bone morphogenetic protein-2 and 3D-printed scaffolds, and wider adoption of microsurgical techniques. These aim to improve healing rates and functional outcomes while minimizing complications.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.